The UK Competition Authority secures binding competition disqualification of pharmaceutical company director involved in two separate anticompetitive arrangements relating to the supply of drugs over a five year period (Amit Patel / Auden McKenzie / Amilco)

Willis, Peter; Wing, Patricia

Previous article The EU Court of Justice Advocate General Kokott proposes to uphold the fine of almost €94 million imposed on a pharmaceutical group in the context of agreements intended to delay the marketing of generic versions of its antidepressant medicinal product citalopram (Lundbeck) Next article The UK Competition Authority secures disqualification of pharmaceutical company director for 5 years for breaching competition law (Amit Patel / Auden McKenzie / Amilco)

4 Jun 2020

The UK Competition Authority secures binding competition disqualification of pharmaceutical company director involved in two separate anticompetitive arrangements relating to the supply of drugs over a five year period (Amit Patel / Auden McKenzie / Amilco)

KEYWORDS

Reference

UK Competition Authority, Amit Patel / Auden McKenzie / Amilco, Press Release, 4 June 2020

On 4 June 2020, the Competition Markets Authority (“CMA”) announced that it had secured binding competition disqualification undertakings by Mr Amit Patel, not to act as a director of any UK company for five years from 13 July 2020, in consequence of his involvement in two separate anti-competitive arrangements relating to the supply of pharmaceuticals in the UK. Background and the law Mr

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

PDF Version

Authors

Peter Willis
Bird & Bird (London)

United Kingdom 28 contributions 3119 visits
Patricia Wing
Orrick, Herrington & Sutcliffe (London)

United Kingdom 4 contributions 581 visits

Quotation

Peter Willis, Patricia Wing, The UK Competition Authority secures binding competition disqualification of pharmaceutical company director involved in two separate anticompetitive arrangements relating to the supply of drugs over a five year period (Amit Patel / Auden McKenzie / Amilco), 4 June 2020, e-Competitions Pay-for-delay agreements, Art. N° 95427

Visites 127